Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
65,570,116
-
Share change
-
+2,269,996
-
Total reported value
-
$6,794,224,190
-
Put/Call ratio
-
88%
-
Price per share
-
$103.61
-
Number of holders
-
300
-
Value change
-
+$243,218,834
-
Number of buys
-
179
-
Number of sells
-
115
Institutional Holders of SALIX PHARMACEUTICALS INC - COM (SLXP) as of Q1 2014
As of 31 Mar 2014,
SALIX PHARMACEUTICALS INC - COM (SLXP) was held by
300 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,570,116 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT CO LLP, VANGUARD GROUP INC, BlackRock Fund Advisors, Bank of New York Mellon Corp, State Street Corp, BlackRock Institutional Trust Company, N.A., Visium Asset Management, LP, AMERIPRISE FINANCIAL INC, and TimesSquare Capital Management, LLC.
This page lists
300
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.